CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-12 | Gano Kyle Chief Executive Officer | Option exercise · Restricted Stock Unit | −4,907 | 14,721 | ||
| 2026-02-12 | Lippoldt Darin Chief Legal Officer | Option exercise | +1,792 | 49,584 | ||
| 2026-02-12 | Lippoldt Darin Chief Legal Officer | Shares withheld for taxes | −967 | $123.10 | $119K | 48,617 |
| 2026-02-12 | Lippoldt Darin Chief Legal Officer | Option exercise · Restricted Stock Unit | −1,792 | 5,377 | ||
| 2026-01-31 | Delaet Ingrid Chief Regulatory Officer | Option exercise | +801 | 5,531 | ||
| 2026-01-31 | Delaet Ingrid Chief Regulatory Officer | Shares withheld for taxes | −475 | $136.06 | $65K | 5,056 |
| 2026-01-31 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Restriced Stock Unit | −801 | 0 | ||
| 2026-01-31 | Boyer David W. Chief Corp. Affairs Officer | Option exercise | +2,096 | 5,902 | ||
| 2026-01-31 | Boyer David W. Chief Corp. Affairs Officer | Shares withheld for taxes | −1,189 | $136.06 | $162K | 4,713 |
| 2026-01-31 | Boyer David W. Chief Corp. Affairs Officer | Option exercise · Restriced Stock Unit | −2,096 | 0 | ||
| 2026-01-31 | Onyia Jude Chief Scientific Officer | Option exercise | +238 | 16,119 | ||
| 2026-01-31 | Onyia Jude Chief Scientific Officer | Shares withheld for taxes | −142 | $136.06 | $19K | 15,977 |
| 2026-01-31 | Onyia Jude Chief Scientific Officer | Option exercise · Restricted Stock Unit | −238 | 0 | ||
| 2026-01-31 | Cooke Julie Chief Human Resources Officer | Option exercise | +1,741 | 28,599 | ||
| 2026-01-31 | Cooke Julie Chief Human Resources Officer | Shares withheld for taxes | −997 | $136.06 | $136K | 27,602 |
| 2026-01-31 | Cooke Julie Chief Human Resources Officer | Option exercise · Restricted Stock Unit | −1,741 | 0 | ||
| 2026-01-31 | ABERNETHY MATT Chief Financial Officer | Option exercise | +2,437 | 38,465 | ||
| 2026-01-31 | ABERNETHY MATT Chief Financial Officer | Shares withheld for taxes | −1,368 | $136.06 | $186K | 37,097 |
| 2026-01-31 | ABERNETHY MATT Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,437 | 0 | ||
| 2026-01-31 | BENEVICH ERIC Chief Commercial Officer | Option exercise | +2,294 | 54,047 |
Page 14 of 49 · 963 trades